Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Shalaby

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
JHEP Reports : Innovation in Hepatology|April 16, 2026
Prognostic value of factor VIII, D-dimer and high molecular risk variants assessing re-thrombosis risk in non-cirrhotic portal vein thrombosisAnna Baiges, Bogdan Procopet, Luis Téllez, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 25, 2021
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort studySarah Shalaby, Martina Taborelli, Alberto Zanetto, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 11, 2026
Hepatic venous pressure gradient, non-invasive tests, and prognosis across the subtypes of advanced steatotic liver diseaseBenedikt S Hofer, Sarah Shalaby, Wilhelmus Kwanten, et al.
Gut|March 20, 2021
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysisVictor Sapena, Marco Enea, Ferran Torres, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
JHEP Reports : Innovation in Hepatology|April 16, 2026
Prognostic value of factor VIII, D-dimer and high molecular risk variants assessing re-thrombosis risk in non-cirrhotic portal vein thrombosisAnna Baiges, Bogdan Procopet, Luis Téllez, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 25, 2021
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort studySarah Shalaby, Martina Taborelli, Alberto Zanetto, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 11, 2026
Hepatic venous pressure gradient, non-invasive tests, and prognosis across the subtypes of advanced steatotic liver diseaseBenedikt S Hofer, Sarah Shalaby, Wilhelmus Kwanten, et al.
Gut|March 20, 2021
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysisVictor Sapena, Marco Enea, Ferran Torres, et al.
Pageof 6